{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:29:04Z","timestamp":1769855344171,"version":"3.49.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:00:00Z","timestamp":1761177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Variants in six pre-mRNA processing factors cause autosomal dominant Retinitis Pigmentosa (adRP). The\n                    <jats:italic>RP9<\/jats:italic>\n                    gene encodes a seventh splicing factor, and in 2002, we published\n                    <jats:italic>RP9<\/jats:italic>\n                    variants c.410A&gt;T; p.(H137L) and c.509A&gt;G; p.(D170G) as likely causes of adRP in a large multigenerational\n                    <jats:italic>RP9<\/jats:italic>\n                    -linked family and a single case, respectively. It has since been suggested these variants might be artefacts due to simultaneous amplification of the\n                    <jats:italic>RP9P<\/jats:italic>\n                    pseudogene, and no further pathogenic variants have been reported. We therefore rescreened two members of the\n                    <jats:italic>RP9<\/jats:italic>\n                    -linked family by genome sequencing. Examination of the 2\u2009Mb locus defined by crossovers in the original family revealed no other plausible causative variants. Alignment of both short and long-read sequences confirmed that p.(H137L) is in the\n                    <jats:italic>RP9<\/jats:italic>\n                    gene, not the pseudogene. Screening for p.(H137L) in 1961 RP\/Rod-cone dystrophy (RCD) cases from the Leeds patient cohort and UK 100,000 Genomes Project (100kGP) database revealed four further carriers. Including the original family, this variant was therefore present in 5\/1962 RP\/RCD probands, and is absent from gnomAD, constituting statistically significant enrichment in RP cases. Long-read sequencing of p.(H137L) in available carriers showed this is a UK founder allele. The\n                    <jats:italic>RP9<\/jats:italic>\n                    p.(D170G) allele was also confirmed as gene, not pseudogene, derived, but is present in 22 individuals in the 100kGP cohort, none with RP, as well as &gt;200 individuals in gnomAD and Biobank, suggesting it is non-pathogenic. In conclusion, RP9 p.(H137L) is strongly associated with RP and remains the only plausible variant accounting for the condition in a large multi-generation adRP family.\n                  <\/jats:p>","DOI":"10.1038\/s41431-025-01964-0","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:05:05Z","timestamp":1761235505000},"page":"227-235","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["RP9 revisited; RP9 p.(H137L) remains a likely cause of dominant splicing factor-Retinitis Pigmentosa"],"prefix":"10.1038","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5223-7616","authenticated-orcid":false,"given":"Leon","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2048-5693","authenticated-orcid":false,"given":"James A.","family":"Poulter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6165-7888","authenticated-orcid":false,"given":"Gavin","family":"Arno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8707-6248","authenticated-orcid":false,"given":"Rajarshi","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5541-4305","authenticated-orcid":false,"given":"Andrew","family":"Lotery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0038-6770","authenticated-orcid":false,"given":"Alison J.","family":"Hardcastle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2371-1844","authenticated-orcid":false,"given":"Christopher M.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5143-2562","authenticated-orcid":false,"given":"Chris F.","family":"Inglehearn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,23]]},"reference":[{"key":"1964_CR1","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1093\/hmg\/10.15.1555","volume":"10","author":"AB McKie","year":"2001","unstructured":"McKie AB, McHale JC, Keen TJ, Tarttelin EE, Goliath R, van Lith-Verhoeven JJ, et al. Mutations in the pre-mRNA splicing factor gene PRPC8 in autosomal dominant retinitis pigmentosa (RP13). Hum Mol Genet. 2001;10:1555\u201362.","journal-title":"Hum Mol Genet"},{"key":"1964_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1097-2765(01)00305-7","volume":"8","author":"EN Vithana","year":"2001","unstructured":"Vithana EN, Abu-Safieh L, Allen MJ, Carey A, Papaioannou M, Chakarova C, et al. A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol Cell. 2001;8:375\u201381.","journal-title":"Mol Cell"},{"key":"1964_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/hmg\/11.1.87","volume":"11","author":"CF Chakarova","year":"2002","unstructured":"Chakarova CF, Hims MM, Bolz H, Abu-Safieh L, Patel RJ, Papaioannou MG, et al. Mutations in HPRP3, a third member of pre-mRNA splicing factor genes, implicated in autosomal dominant retinitis pigmentosa. Hum Mol Genet. 2002;11:87\u201392.","journal-title":"Hum Mol Genet"},{"key":"1964_CR4","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1093\/hmg\/ddu005","volume":"23","author":"X Chen","year":"2014","unstructured":"Chen X, Liu Y, Sheng X, Tam PO, Zhao K, Chen X, et al. PRPF4 mutations cause autosomal dominant retinitis pigmentosa. Hum Mol Genet. 2014;23:2926\u201339.","journal-title":"Hum Mol Genet"},{"key":"1964_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ajhg.2011.04.008","volume":"88","author":"G Tanackovic","year":"2011","unstructured":"Tanackovic G, Ransijn A, Ayuso C, Harper S, Berson EL, Rivolta C. A missense mutation in PRPF6 causes impairment of pre-mRNA splicing and autosomal-dominant retinitis pigmentosa. Am J Hum Genet. 2011;88:643\u20139.","journal-title":"Am J Hum Genet"},{"key":"1964_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ajhg.2009.09.020","volume":"85","author":"C Zhao","year":"2009","unstructured":"Zhao C, Bellur DL, Lu S, Zhao F, Grassi MA, Bowne SJ, et al. Autosomal-dominant retinitis pigmentosa caused by a mutation in SNRNP200, a gene required for unwinding of U4\/U6 snRNAs. Am J Hum Genet. 2009;85:617\u201327.","journal-title":"Am J Hum Genet"},{"key":"1964_CR7","doi-asserted-by":"publisher","unstructured":"Quindoz M, Rodenburg K, Cvackova Z, Kaminska K, De Bruijn SE, Iglasias-Romero AB, et al. De novo and inherited dominant variants in U4 and U6 snRNAs cause retinitis pigmentosa. Preprint at. 2025. https:\/\/doi.org\/10.1101\/2025.01.06.24317169.","DOI":"10.1101\/2025.01.06.24317169"},{"key":"1964_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/ncb3201","volume":"17","author":"G Wheway","year":"2015","unstructured":"Wheway G, Schmidts M, Mans DA, Szymanska K, Nguyen TT, Racher H, et al. An siRNA-based functional genomics screen for the identification of regulators of ciliogenesis and ciliopathy genes. Nat Cell Biol. 2015;17:1074\u201387.","journal-title":"Nat Cell Biol"},{"key":"1964_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/jmg.29.12.906","volume":"29","author":"M Jay","year":"1992","unstructured":"Jay M, Bird AC, Moore AN, Jay B. Nine generations of a family with autosomal dominant retinitis pigmentosa and evidence of variable expressivity from census records. J Med Genet. 1992;29:906\u201310.","journal-title":"J Med Genet"},{"key":"1964_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ng0593-51","volume":"4","author":"CF Inglehearn","year":"1993","unstructured":"Inglehearn CF, Carter SA, Keen TJ, Lindsey J, Stephenson AM, Bashir R, et al. A new locus for autosomal dominant retinitis pigmentosa on chromosome 7p. Nat Genet. 1993;4:51\u201353.","journal-title":"Nat Genet"},{"key":"1964_CR11","first-page":"675","volume":"54","author":"CF Inglehearn","year":"1994","unstructured":"Inglehearn CF, Keen TJ, Al-Maghtheh M, Gregory CY, Jay MR, Moore AT, et al. Further refinement of the location for autosomal dominant retinitis pigmentosa on chromosome 7p (RP9). Am J Hum Genet. 1994;54:675\u201380.","journal-title":"Am J Hum Genet"},{"key":"1964_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/sj.ejhg.5200797","volume":"10","author":"TJ Keen","year":"2002","unstructured":"Keen TJ, Hims MM, McKie AB, Moore AT, Doran RM, Mackey DA, et al. Mutations in a protein target of the Pim-1 kinase associated with the RP9 form of autosomal dominant retinitis pigmentosa. Eur J Hum Genet. 2002;10:245\u20139.","journal-title":"Eur J Hum Genet"},{"key":"1964_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.yexcr.2004.07.029","volume":"300","author":"H Maita","year":"2004","unstructured":"Maita H, Kitaura H, Keen TJ, Inglehearn CF, Ariga H, Iguchi-Ariga SM. PAP-1, the mutated gene underlying the RP9 form of dominant retinitis pigmentosa, is a splicing factor. Exp Cell Res. 2004;300:283\u201396.","journal-title":"Exp Cell Res"},{"key":"1964_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.yexcr.2004.08.022","volume":"302","author":"H Maita","year":"2005","unstructured":"Maita H, Kitaura H, Ariga H, Iguchi-Ariga SM. Association of PAP-1 and Prp3p, the products of causative genes of dominant retinitis pigmentosa, in the tri-snRNP complex. Exp Cell Res. 2005;302:61\u201368.","journal-title":"Exp Cell Res"},{"key":"1964_CR15","first-page":"864","volume":"59","author":"M Al-Maghtheh","year":"1996","unstructured":"Al-Maghtheh M, Vithana E, Tarttelin E, Jay M, Evans K, Moore T, et al. Evidence for a major retinitis pigmentosa locus on 19q13.4 (RP11) and association with a unique bimodal expressivity phenotype. Am J Hum Genet. 1996;59:864\u201371.","journal-title":"Am J Hum Genet"},{"key":"1964_CR16","doi-asserted-by":"publisher","first-page":"e17084","DOI":"10.1371\/journal.pone.0017084","volume":"6","author":"ZB Jin","year":"2011","unstructured":"Jin ZB, Okamoto S, Osakada F, Homma K, Assawachananont J, Hirami Y, et al. Modelling retinal degeneration using patient-specific induced pluripotent stem cells. PLoS ONE. 2011;6:e17084.","journal-title":"PLoS ONE"},{"key":"1964_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep43062","volume":"7","author":"JN Lv","year":"2017","unstructured":"Lv JN, Zhou GH, Chen X, Chen H, Wu KC, Xiang L, et al. Targeted RP9 ablation and mutagenesis in mouse photoreceptor cells by CRISPR-Cas9. Sci Rep. 2017;7:43062.","journal-title":"Sci Rep"},{"key":"1964_CR18","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1167\/iovs.05-1443","volume":"47","author":"LS Sullivan","year":"2006","unstructured":"Sullivan LS, Bowne SJ, Birch DG, Hughbanks-Wheaton D, Heckenlively JR, Lewis RA, et al. Prevalence of disease-causing mutations in families with autosomal dominant retinitis pigmentosa: a screen of known genes in 200 families. Invest Ophthalmol Vis Sci. 2006;47:3052\u201364.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1964_CR19","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1093\/bioinformatics\/btt314","volume":"29","author":"C Raczy","year":"2013","unstructured":"Raczy C, Petrovski R, Saunders CT, Chorny I, Kruglyak S, Margulies EH, et al. Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms. Bioinformatics. 2013;29:2041\u20133.","journal-title":"Bioinformatics"},{"key":"1964_CR20","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"1964_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43:491\u20138.","journal-title":"Nat Genet"},{"key":"1964_CR22","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1093\/bioinformatics\/bts526","volume":"28","author":"V Plagnol","year":"2012","unstructured":"Plagnol V, Curtic J, Epstein M, Mok KY, Stebbings E, Grigoriadou S, et al. A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics. 2012;28:2747\u201354.","journal-title":"Bioinformatics"},{"key":"1964_CR23","doi-asserted-by":"crossref","unstructured":"Rivolta C, Celik E, Kamdar D, Cancellieri F, Kaminska K, Ullah M, et al. RetiGene, a comprehensive gene atlas for inherited retinal diseases. Am J Hum Genet. 2025;112:2253\u201365.","DOI":"10.1016\/j.ajhg.2025.08.017"},{"key":"1964_CR24","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310\u20135.","journal-title":"Nat Genet"},{"key":"1964_CR25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/humu.22225","volume":"34","author":"HA Shihab","year":"2013","unstructured":"Shihab HA, Gough J, Cooper DN, Stenson PD, Barker GL, Edwards KJ, et al. Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat. 2013;34:57\u201365.","journal-title":"Hum Mutat"},{"key":"1964_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giad024","volume":"12","author":"M Schubach","year":"2022","unstructured":"Schubach M, Nazaretyan L, Kircher M. The regulatory Mendelian mutation score for GRCh38. Gigascience. 2022;12:giad024.","journal-title":"Gigascience"},{"key":"1964_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"1964_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-1-40","volume":"1","author":"C Hamel","year":"2006","unstructured":"Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1:40.","journal-title":"Orphanet J Rare Dis"},{"key":"1964_CR29","doi-asserted-by":"crossref","unstructured":"Cheng J, Novati G, Pan J, Bycroft C, \u017demgulyt\u0117 A, Applebaum T, et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 2023;381:eadg7492.","DOI":"10.1126\/science.adg7492"},{"key":"1964_CR30","first-page":"860","volume":"15","author":"ES Lander","year":"2001","unstructured":"Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial sequencing and analysis of the human genome. Nature. 2001;409:860\u2013921.","journal-title":"Nature"},{"key":"1964_CR31","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/nbt1486","volume":"26","author":"J Shendure","year":"2008","unstructured":"Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol. 2008;26:1135\u201345.","journal-title":"Nat Biotechnol"},{"key":"1964_CR32","doi-asserted-by":"publisher","unstructured":"The National Genomic Research Library v5.1, Genomics England. https:\/\/doi.org\/10.6084\/m9.figshare.4530893.v7.","DOI":"10.6084\/m9.figshare.4530893.v7"},{"key":"1964_CR33","first-page":"1259","volume":"26","author":"D Mordes","year":"2006","unstructured":"Mordes D, Luo X, Kar A, Kuo D, Xu L, Fushimi F, et al. Pre-mRNA splicing and retinitis pigmentosa. Mol Vis. 2006;26:1259\u201371.","journal-title":"Mol Vis"},{"key":"1964_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/9722","volume":"22","author":"EM Stone","year":"1999","unstructured":"Stone EM, Lotery AJ, Munier FL, Heon E, Piguet B, Guymer RH, et al. A single EFEMP1 mutation associated with both malattia leventinese and Doyne honeycomb retinal dystrophy. Nat Genet. 1999;22:199\u2013202.","journal-title":"Nat Genet"},{"key":"1964_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/bjo.77.8.473","volume":"77","author":"AT Moore","year":"1993","unstructured":"Moore AT, Fitzke F, Jay M, Arden GB, Inglehearn CF, Keen TJ, et al. Autosomal dominant retinitis pigmentosa with apparent incomplete penetrance: a clinical, electrophysiological, psychophysical, and molecular genetic study. Br J Ophthalmol. 1993;77:473\u20139.","journal-title":"Br J Ophthalmol"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01964-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01964-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01964-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:46:06Z","timestamp":1769769966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01964-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,23]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1964"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01964-0","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,23]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CMW has received travel expenses from Oxford Nanopore Technologies. All other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"For patients recruited in Leeds and in collaborating sites throughout the UK, informed written consent was obtained using a protocol that followed the precepts of the Declaration of Helsinki and was approved by the Leeds East Research Ethics Committee (Project reference 17\/YH\/0032). The 100,000 Genomes Project is covered by REC reference approval 14\/EE\/1112.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}